Zanubrutinib in Combination With Odronextamab for the Treatment of Patients With Richter's Transformation — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
United States
City of Hope Medical Center, Duarte, California Last updated September 2025